<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05024708</url>
  </required_header>
  <id_info>
    <org_study_id>35RC21_9886_CA2VD</org_study_id>
    <nct_id>NCT05024708</nct_id>
  </id_info>
  <brief_title>Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)</brief_title>
  <acronym>CA2VD</acronym>
  <official_title>Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, nonrandomized, single-center, comparative study to define if right ventricular&#xD;
      (RV) contractile reserve assessed by exercise CMR helps to improve the differential diagnosis&#xD;
      between pathological and physiological remodeling of the RV; ie. arrhythmogenic right&#xD;
      ventricular cardiomyopathy (ARVC) and athlete's heart.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of the RV contractile reserve in 4 groups of patients: Arrhythmogenic right&#xD;
      ventricular cardiomyopathy (ARVC) patients; endurance athletes with a dilated RV, endurance&#xD;
      athletes with normal RV, untrained subject with normal RV.&#xD;
&#xD;
      Patients will come to the hospital for 3 visits (3 half days):&#xD;
&#xD;
        -  Visit 1: clinical evaluation, rest ECG, rest echocardiography, cardio-pulmonary exercise&#xD;
           test.&#xD;
&#xD;
        -  Visit 2: exercise echocardiography, holter ECG monitor (48 yours)&#xD;
&#xD;
        -  Visit 3: rest CMR and exercise CMR (ergocycle)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of right ventricular ejection fraction (RVEF) assessed with CMR during exercise</measure>
    <time_frame>Through study completion, an average of 1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of Tricuspid annular plane systolic excursion (TAPSE) during exercise</measure>
    <time_frame>Through study completion, an average of 1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of S' tricuspid wave during exercise</measure>
    <time_frame>Through study completion, an average of 1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of RV fractional area during exercise</measure>
    <time_frame>Through study completion, an average of 1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of free wall RV strain during exercise</measure>
    <time_frame>Through study completion, an average of 1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Arrhythmogenic Right Ventricular Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>ARVC patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Endurance athletes with a dilated RV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Endurance athletes with normal RV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Untrained subject with normal RV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac exercises and tests</intervention_name>
    <description>Rest ECG, rest echocardiography, cardio-pulmonary exercise test, exercise echocardiography, holter ECG monitor (48 yours), rest CMR, exercise CMR (ergocycle)</description>
    <arm_group_label>ARVC patients</arm_group_label>
    <arm_group_label>Endurance athletes with a dilated RV</arm_group_label>
    <arm_group_label>Endurance athletes with normal RV</arm_group_label>
    <arm_group_label>Untrained subject with normal RV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men or women aged 18 years and older,&#xD;
&#xD;
               -  patients with confirmed ARVC, but with no major RV dysfunction (RVEF &gt;40%)&#xD;
&#xD;
               -  endurance athletes with dilated RV&#xD;
&#xD;
               -  endurance athletes with non-dilated RV&#xD;
&#xD;
               -  untrained healthy subjects with non-dilated RV&#xD;
&#xD;
          -  who signed a written free and informed consent:&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with other cardiovascular disease;&#xD;
&#xD;
          -  Contra-indication to CMR (in particular presence of a non-CMR compatible implantable&#xD;
             cardiac defibrillator);&#xD;
&#xD;
          -  Patients with permanent supraventricular arrhythmia;&#xD;
&#xD;
          -  Patients unable to perform an exercise test on an ergocycle;&#xD;
&#xD;
          -  Person subject to legal protection (safeguard justice, trusteeship and guardianship)&#xD;
             and persons deprived of liberty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frédéric SCHNELL, MD-PhD</last_name>
    <phone>+33 2.99.28.41.33</phone>
    <email>Frederic.SCHNELL@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Frédéric SCHNELL, MD-PhD</last_name>
      <phone>+33 2.99.28.41.33</phone>
      <email>Frederic.SCHNELL@chu-rennes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Elise BANNIER, PhD</last_name>
      <phone>+33 2 99 28 99 06</phone>
      <email>elise.bannier@irisa.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 23, 2021</study_first_submitted>
  <study_first_submitted_qc>August 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ARVC, Athlete's heart, exercise, CMR, RV contractile reserve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Arrhythmogenic Right Ventricular Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

